Finance

Beta
Lists
PRE:NASDAQ
Prenetics Global Ltd
$20.93
+4.65%
(+0.93) 1D
$20.93
0.00% (0.00)
After hours
Closed: Jun 9, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PRE...
Open
$20.25
High
$21.00
Low
$19.50
Mkt. cap
358.81M
Avg. vol.
266.46K
Volume
295.63K
52-wk high
$23.63
52-wk low
$6.88
EPS
-$2.42
Beta
0.30
Shares outstanding
15.56M
No. of employees
98
Open
$20.25
High
$21.00
Low
$19.50
Mkt. cap
358.81M
Avg. vol.
266.46K
Volume
295.63K
52-wk high
$23.63
52-wk low
$6.88
EPS
-$2.42
Beta
0.30
Shares outstanding
15.56M
No. of employees
98
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to PRE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PRE in the last 3 months.
Highest
Current $20.93
$36.00 (+72.00%)
Average
$32.50 (+55.28%)
Lowest
$29.00 (+38.56%)
News stories
From sources across the web
Profile
Prenetics is a health sciences company headquartered in Hong Kong, with a presence in the United States. It focuses on early detection, prevention, and treatment of diseases, particularly cancer. Its subsidiary brands include CircleDNA, Insighta and IM8. Wikipedia
About Prenetics Global Ltd
CEO-
Employees98
Founded2014
Headquarters-
SectorHealth care provider
Websiteprenetics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
17.31M
14.96M
23.56M
36.56M
Cost of goods sold
9.97M
9.13M
9.53M
14.97M
Cost of revenue
9.97M
9.13M
9.53M
14.97M
Research and development expenses
2.42M
803.00K
1.17M
743.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.87M
12.52M
19.41M
34.13M
Operating expense
17.97M
13.52M
20.19M
35.17M
Total operating expenses
27.94M
22.65M
29.72M
50.14M
Operating income
-10.63M
-7.68M
-6.16M
-13.58M
Other non operating income
-63.00K
-637.00K
96.00K
9.59M
EBT including unusual items
-11.07M
-8.70M
-6.78M
-9.66M
EBT excluding unusual items
-11.07M
-8.60M
-6.78M
-3.87M
Income tax expense
-64.00K
51.00K
9.00K
38.00K
Effective tax rate
0.58%
-0.59%
-0.13%
-0.39%
Other operating expenses
-312.00K
194.00K
-395.00K
297.00K
Net income
-10.39M
-12.41M
-7.41M
-7.50M
Net profit margin
-60.02%
-82.93%
-31.45%
-20.52%
Earnings per share
-
-
-
-0.19
Interest and investment income
-
731.00K
-
1.20M
Interest expense
-69.00K
-72.00K
-55.00K
-45.00K
Net interest expenses
-69.00K
659.00K
-55.00K
1.15M
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.80M
-6.75M
-5.33M
-13.34M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer